Every week, Pause's reports flag insider transactions across the companies you own — a CEO selling shares, a director exercising options, sometimes several executives filing in the same week. Most of it is routine. Some of it isn't. Here's how to actually tell the difference, instead of treating every insider sale as a red flag.
The single most useful fact in any Form 4 is whether the sale happened under a Rule 10b5-1 trading plan. These plans are set up in advance — often months earlier, when an executive has no access to material non-public information — and they execute automatically on a schedule, regardless of what's happening at the company that week. A sale under a pre-arranged plan isn't the executive reacting to anything happening right now. It's a calendar entry going off.
A discretionary sale — one made without a pre-arranged plan, at a moment the executive chose deliberately — is rarer, and worth more attention, because they picked that specific time to sell.
Most reported insider selling is the first kind. It reads the same in a headline — "CEO sold $12 million in stock" — but it means something very different.
One executive selling under a routine plan is unremarkable — it happens constantly, often for reasons as mundane as covering a tax bill on vested stock. It's worth more attention when multiple executives sell in the same window — a CEO, a CFO, and two directors all filing within the same week, for example. That doesn't prove anything on its own, but it's a meaningfully different pattern than one person's scheduled sale, and it's worth knowing the difference exists before reacting to either.
A sale means something different depending on how much of the executive's position it represents. Selling 5,000 shares out of 2 million owned isn't the same as selling most of a remaining stake. Form 4s report shares owned after the transaction — that number is sitting right there in the filing, and it's worth a glance before reacting to the dollar figure in a headline.
A lot of what gets reported as "executive sold shares" is actually an option exercise followed by an immediate sale — realizing compensation already earned, not a fresh decision to part with shares they'd otherwise keep. That's extremely common and, on its own, close to routine. It's a different fact than an executive selling shares they'd simply held for years, with no options involved.
Everything above explains why a sale, on its own, usually isn't much of a signal — there are too many routine, mundane reasons an executive might sell that have nothing to do with their view of the company. An insider buy doesn't have the same list of routine explanations.
Executives are already paid heavily in stock and options — their compensation is often concentrated in the company they run before they ever place a single trade. There's no tax bill that requires buying more shares, no vesting schedule that hands them new stock to sell, no diversification need that a purchase would satisfy. When an executive spends their own cash to buy shares on the open market, it strips away nearly all of the routine explanations that make sales ambiguous.
That's why insider buying is generally treated as a cleaner signal than insider selling, even though the two might look symmetrical on the surface. It's not proof of anything on its own — a purchase can still be a small, symbolic amount relative to someone's overall wealth, or timed for reasons that have nothing to do with the business. But the asymmetry is real: selling has a dozen mundane explanations, buying mostly has one.
In one week's reports, Pause previously saw Rocket Lab's CEO sell roughly 3.57 million shares for about $290 million — a large number on its face. But the filings show it executed under a pre-arranged plan, across a scheduled window, alongside a separate, unrelated piece of news (an analyst downgrade) that had nothing to do with the sale itself.
That same week, Planet Labs saw its CEO, a co-founder, and two directors all file sales within days of each other — also under pre-arranged plans, but as a cluster rather than a single filer. Neither case is inherently alarming. But they're genuinely different patterns, and treating them identically — "insiders are selling" — would flatten a real distinction that the filings themselves make visible, if you know what to look for.
No single Form 4 tells you much in isolation. What's actually informative is the pattern over time: is this executive's selling consistent with prior scheduled sales, or a break from it? Is this the first cluster of multiple insiders selling together, or does it happen most quarters? Context from prior weeks matters more than any one filing.
Every week, when insider activity shows up in your reports, Pause reports the mechanics plainly — plan type, filer role, size relative to remaining holdings — without telling you what to conclude from it. That's deliberate: whether a given sale matters depends on the pattern you're watching, not a single number in isolation.
No opinions, no recommendations — just compiled facts, exactly like every subscriber gets. Build your own free portfolio and see it for your own stocks.
Start free →